Detalhe da pesquisa
1.
Novel induction of CD40 expression by tumor cells with RAS/RAF/PI3K pathway inhibition augments response to checkpoint blockade.
Mol Cancer
; 20(1): 85, 2021 06 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34092233
2.
BCL-xL inhibition potentiates cancer therapies by redirecting the outcome of p53 activation from senescence to apoptosis.
Cell Rep
; 41(12): 111826, 2022 12 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36543138
3.
Metastatic Melanoma Patient-Derived Xenografts Respond to MDM2 Inhibition as a Single Agent or in Combination with BRAF/MEK Inhibition.
Clin Cancer Res
; 26(14): 3803-3818, 2020 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32234759